“Life sciences” is a common name of a raft of sciences dealing with living organisms and various types of life processes. The life sciences industry can be divided into several sub-groups such as Biotech & Pharma, healthcare, medical devices, research and lab services. Pharmaceuticals form the largest market sector; its sales are predicted to override USD 1 trillion by 2015.
The life sciences market proved to be rather resistant to unfavorable economic conditions. It has experienced healthy growth over the recent years on the back of the population increase, ongoing technological advancements and rising awareness of healthcare. Drug discovery, medical equipment and regenerative medicine represent the most promising market sectors.
A wealthy collection of the research reports providing extensive overview of the life sciences market is at hand in this MarketPublishers’ catalogue. Current situation and historic development of the market are reviewed in the researches. The reports thoroughly examine market segments, disclose essential information on the market size and characterize the industry dynamics and identify major forces shaping the market. Moreover, the long-term and short-term future outlooks for the market can be found in the research reports.
Publications found:
253,840
Sort by:
Infections Malaria Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Malaria Therapy Area Pipeline Report contains detailed information on the malaria drug pipeline. This report provides insight into the pipeline status of malaria drugs by comp...
January 2010
338 pages
Infections Onychomycosis Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Onychomycosis Therapy Area Pipeline Report contains detailed information on the onychomycosis drug pipeline. This report provides insight into the pipeline status of onychomyc...
January 2010
85 pages
Infections Pneumonia Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Pneumonia Therapy Area Pipeline Report contains detailed information on the pneumonia drug pipeline. This report provides insight into the pipeline status of pneumonia drugs b...
January 2010
204 pages
Infections Sepsis Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Sepsis Therapy Area Pipeline Report contains detailed information on the sepsis drug pipeline. This report provides insight into the pipeline status of sepsis drugs by company...
January 2010
74 pages
Infections Tetanus Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Tetanus Therapy Area Pipeline Report contains detailed information on the tetanus drug pipeline. This report provides insight into the pipeline status of tetanus drugs by comp...
January 2010
114 pages
Infections Throat Infection Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Throat Infection Therapy Area Pipeline Report contains detailed information on the throat infection drug pipeline. This report provides insight into the pipeline status of thr...
January 2010
68 pages
Infections Tuberculosis Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Tuberculosis Therapy Area Pipeline Report contains detailed information on the tuberculosis drug pipeline. This report provides insight into the pipeline status of tuberculosi...
January 2010
337 pages
Infections Viral Infections Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Viral Infections Therapy Area Pipeline Report contains detailed information on the viral infections drug pipeline. This report provides insight into the pipeline status of vir...
January 2010
201 pages
Metabolic Endocrinology Obesity Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Obesity Therapy Area Pipeline Report contains detailed information on the obesity drug pipeline. This report provides insight into the pipeline status of obesity drugs by comp...
January 2010
322 pages
Musculo-Skeletal-Disorders Gout Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Gout Therapy Area Pipeline Report contains detailed information on the gout drug pipeline. This report provides insight into the pipeline status of gout drugs by company and b...
January 2010
135 pages
